Allergic Rhinitis News and Research

RSS
Nuvo obtains Health Canada approval to conduct WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo obtains Health Canada approval to conduct WF10 Phase 2 trial for treatment of allergic rhinitis

Nuvo Research provides details of new WF10 Phase 2 clinical trial for treatment of allergic rhinitis

Nuvo Research provides details of new WF10 Phase 2 clinical trial for treatment of allergic rhinitis

New article shows how marijuana can act as an allergen

New article shows how marijuana can act as an allergen

Shire announces acquisition of Meritage Pharma

Shire announces acquisition of Meritage Pharma

Experts recommend sublingual immunotherapy for treatment of allergic rhinitis

Experts recommend sublingual immunotherapy for treatment of allergic rhinitis

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Oral budesonide suspension offers hope for pediatric patients with EoE

Oral budesonide suspension offers hope for pediatric patients with EoE

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Nuvo Research completes WF10 Phase 2 trial in patients with refractory allergic rhinitis

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Exposure to indoor air pollution affects children's lungs

Exposure to indoor air pollution affects children's lungs

Children infected with enterovirus more likely to have type 1 diabetes

Children infected with enterovirus more likely to have type 1 diabetes

Researchers working to develop new drugs for treating chronic inflammatory diseases

Researchers working to develop new drugs for treating chronic inflammatory diseases

Reforestation can reduce ragweed pollen that triggers hay fever

Reforestation can reduce ragweed pollen that triggers hay fever

AeraMax air purifiers reduce exposure to allergens

AeraMax air purifiers reduce exposure to allergens

Knowing summer allergies

Knowing summer allergies

Researchers identify target molecules for development of new allergy drugs

Researchers identify target molecules for development of new allergy drugs

Researchers identify several target molecules suitable for development of new allergy drugs

Researchers identify several target molecules suitable for development of new allergy drugs

Scientists shed light on runny nose

Scientists shed light on runny nose

Access provides update on new formulation of anti-inflammatory drug amlexanox

Access provides update on new formulation of anti-inflammatory drug amlexanox